Bourse de Tunis
Unite de Fabrication de Medicaments SA · UMED.TN
Historique des prix
Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has labaroatories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers. The Company's product portfolio comprises Ophthalmology Otorhinolaryngologicals (OPHTA ORL) like Alzor, Atropine Unimed and Benzosept, among others; liquid injections, such as Bupicaine, Furoxem, Doperan and Ketomed, among others; powders for injections, such as Amoxil, Ampicil and Cefaxone, among others; Otorhinolaryngologicals (ORL) like Ofloxacine; and infusion solutions, such as Glucose 5% and Osmomed 5%, among others.
Fondamentaux
connectez-vous pour voir plusConnectez-vous pour débloquer l'historique complet des fondamentaux.
Se connecter| Indicateur (TND, M) | 2025 2025 | 2024 2024 | 2023 2023 | 2022 2022 | 2021 2021 |
|---|---|---|---|---|---|
| Chiffre d'affaires Total Revenue | 160 | ||||
| EBITDA | 59 | ||||
| EBIT | 40.9 | ||||
| Résultat net Net Income | 23.6 | ||||
| Marge nette Net margin | 14.75% |